DAFTAR PUSTAKA

1. Lawrence H.S and Valentine F.T. Transfer factor and other mediators of cellular immunity. American Journal of Pathology. 1970;60(3):437-52. 2. Kuswibawati, Luciana. 2000. Apa Itu Kanker. Yogyakarta: Penerbit Universitas Sanata Dharma. 3. Hanahan D and Weinberg R.A. The Hallmarks of Cancer.2000.Cell;100:57 70. 4. Hamblin A.S. Transfer factor. Journal of the Royal Society of Medicine. 1979;72:927-29. 5. Levine P.H, Pizza G, AjmeraK, Vinci C.D, Viza D. Transfer Factor in Virus Associated Malignancies: An Underestimated Weapon in prevention and Treatment of cancer. Advances in Tumor Virology 2011:2 720. 6. Belli H.L. Peran kolostrum dalam transfer imunitas pasif pada anak sapi baru lahir. Wartazoa. 2009;19(2):76-83. 7. Zuckerman K. S, Nemiait J.A, Balcerzak S.P, and Lobugco A. F. Immunologic specificity of transfer factor. The Journal of Clinical Investigation. 1974;54:997-1000. 8. Kirkpatrick C.H. Transfer Factors: Identication of conserved sequences in transfer factor molecules. Molecular Medicine. Molecular Medicine 6(4): 332341, 2000;6(4): 332341. 9. Kartawiguna E. Faktor-faktor yang berperan pada karsinogenesis. Jurnal Kedokter Trisakti.2001:20;16-26. 10. Otto, Sherly E. 2003. Buku Saku Keperawatan Onkologi. Jakarta: Penerbit Buku Kedokteran EGC. 11. Eichhorn M.E, Kleespies, Angele M. K, Jauch K.W, Bruns C.J. Angiogenesis in cancer: molecular mechanisms, clinical impact. Langenbecks Arch Surg. 2007;392:371379. 12. Rosenfeld S and Dressler D. Transfer Factor: A Subcellular Component that Transmits Information for Specific Immune Responses. Proc. Nat. Acad. Sci. USA. 1974;71(6) 2473-2477.

13. Kikpatrick C.H, Rich R.R, and Smith T.K. Effect of transfer factor on lymphocyte function in anergic patients. The Journal of Clinical Investigation. 1972;51:2948-58. 14. Fabre R.A, Prez T. M, Aguilar L.D, Rangel M.J, Estrada-garca I, Hernndez-pando I, Parra S. E. Transfer factors as immunotherapy and supplement of chemotherapy in experimental pulmonary tuberculosis. Clin Exp Immunol. 2004;136:215223. 15. Oettgen H.F, Old L.J, Farrow J.H, Valentinet F.T, Lawrence H.S, and Thomas L. Effects of dialyzable transfer factor in patients with breast cancer. Proc. Nat. Acad. Sci. USA. 1974;71(6):2319-2323. 16. Vetto R.M, Burger D.R, Nolte J.E, Vandenbark A.A, and Baker H.W. Transfer factor therapy in patients with cancer. Cancer.1976;37:90-97. 17. http://www.4vidas.com. The Basics of Transfer Factor. Download tanggal 25 November 2012. 18. Ibrahim S, Wahid S. Review. Immunotherapy on breast cancer: the update. The Indonesian Journal of Medical Science. 2010;2(1):54-60. 19. Lara H.H, Turrent L.I, Garza-Trevio E.N, Tamez-Guerra R, and RodriguezPadilla C. Clinical and immunological assessment in breast cancer patients receiving anticancer therapy and bovine dialyzable leukocyte extract as an adjuvant. Experimental and Therapeutic Medicine.2010:1;425-431. 20. Pilotti V, Mastrorilli M, Pizza G, De Vinci C, Busutti L, Palareti A, Gozzetti G, Cavallari A. Transfer factor as an adjuvant to non-small cell lung cancer (NSCLC) therapy. Biotherapy. 1996;9(1-3):117-21. 21. Whyte R.I, Schork M.A, Sloan H, Orringer M.B, and Kirsh M.M. Adjuvant treatment using transfer factor for bronchogenic carcinoma: long-term followup. Ann Thorac Surg.1992;53:391-6. 22. Prasad U bin Jalaludin MA, Rajadurai P, Pizza G, De Vinci C, Viza D, Levine P.H . Transfer factor with anti-EBV activity as an adjuvant therapy for nasopharyngeal carcinoma: a pilot study. Biotherapy 1996;9(1-3):109-15.

23. Levin A.S, Byers V.S, Fudenberg H.H, Wybran J, Hackett A.J, Johnston J.O, and Spitler L.E. Osteogenic Sarcoma Immunologic parameters before and during immunotherapy with tumor-specific transfer factor. Journal of Clinical Investigation. 1975;55:487-499. 24. Pizza G, Viza D, Boucheixt.C, and Corrado F. In vitro production of a transfer factor specific for transitional-cell carcinoma of the bladder. Br. J. Cancer (1976);33:606-11. 25. Pizza G, De Vinci C, Cuzzocrea D, Menniti D, Aiello E, Maver P, Corrado G, Romagnoli P, Dragoni E, Lo Conte G, Riolo U, Palareti A, Zucchelli P, Fornarola V, Viza D. A preliminary report on the use of transfer factor for treating stage D3 hormone-unresponsive metastatic prostate cancer. Biotherapy 1996;9(1-3):123-32. 26. White Aaron. A guide to transfer factor and immune system health second edition. 2009. BookSurge:USA. 27. Albers A. E, Strauss L, Liao T, Hoffmann T.K, Kaufmann A.M. Review Article T Cell-Tumor Interaction Directs the Development of Immunotherapies in Head and Neck Cancer. Clinical and Developmental Immunology. 2010;1-14.